Scroll to top

Managing Director’s AGM Presentation

27 November 2017

Today’s discussion outlines the CLINUVEL Board’s objectives to lead the growth of the Group by 2020. The emphasis today is on the strategic direction of the Group towards growth by 2020. Audiences unfamiliar with CLINUVEL are encouraged to review the website at www.clinuvel.com. Three elements have dictated CLINUVEL’s Board strategic considerations. CLINUVEL intends:

  • to maintain “situational awareness”;
  • to leverage the melanocortin technology (SCENESSE®)/knowledge; and
  • to lend more visibility to the CLINUVEL brand. The audience is asked to keep these three elements in mind when travelling into the future of the CLINUVEL Group

 Download PDF for more

We use cookies to give you the best experience.